Last updated: February 27, 2026
What is NDC 54738-0035?
NDC 54738-0035 refers to a specific formulation of a drug in the National Drug Code (NDC) system. According to the FDA database, this NDC is associated with Adapalene Gel 0.1%, used for the topical treatment of acne vulgaris. It is marketed under the brand name Differin.
Market Size and Dynamics
Current Market Landscape
- Global Acne Treatment Market: Valued at approximately $7.8 billion in 2022, projected to reach $11.5 billion by 2028, growing at a CAGR of 6.7% [1].
- Topical Retinoids Segment: Dominates due to efficacy and safety profile, with adapalene accounting for a significant market share within this segment.
- Key Competitors: Differin (Galderma), Epiduo (GlaxoSmithKline), Tazorac (Allergan), and generic versions.
Regulatory and Patent Status
- Patent: Differin’s patent expired in the U.S. in 2020, introducing generic competition.
- FDA Approvals: Approved since 2016 for over-the-counter (OTC) use, expanding market accessibility.
- Market Entry: Generics are widely available, causing price competition but also increasing market volume.
Prescription and OTC Trends
- Prescription Sales: Account for roughly 65% of market value pre-2020.
- OTC Sales: Expanded significantly after FDA approval, accounting for an estimated 35% of sales in 2022 [2].
Price Trends and Projections
Current Pricing (2023)
| Market Segment |
Estimated Average Price (USD) per 30g tube |
| Prescription (brand) |
$140 – $160 |
| Prescription (generic) |
$50 – $70 |
| OTC (brand) |
$25 – $35 |
| OTC (generic) |
$10 – $20 |
Historical Price Dynamics
- Pre-2020: Brand Differin advertised at approximately $150 per tube.
- Post-2020: Entry of generics reduced prices by up to 60% in the prescription segment.
Future Price Dynamics (2024-2028)
- Generic Market Penetration: Continues to exert downward pressure, with expected price declines of approximately 10% annually in the OTC segment.
- Regulatory Changes: Potential for further OTC approvals could lead to price stabilization or modest increases due to increased market volume.
- Pricing Predictions:
| Year |
OTC (generic) |
Prescription (generic) |
Brand OTC |
Brand Prescription |
| 2024 |
$8 – $15 |
$45 – $65 |
$20 – $30 |
$165 – $180 |
| 2025 |
$7 – $13 |
$40 – $60 |
$18 – $28 |
$160 – $175 |
| 2026 |
$6 – $12 |
$35 – $55 |
$16 – $26 |
$150 – $170 |
Revenue Figures
- Overall, the market for adapalene products is expected to generate approximately $2.7 billion in 2023.
- As generics dominate, pricing will trend downward, but increased market penetration and OTC availability could stabilize revenues for leading brands.
Strategic Implications
- Competitive Pricing: Companies competing in this segment should anticipate continued price erosion.
- Patent Litigation: Patent expirations in 2020 make brand differentiation difficult; focus shifts to formulations and marketing.
- Market Expansion: OTC status broadens consumer base, but price competition intensifies.
Key Takeaways
- The global acne treatment market is experiencing steady growth, with topical retinoids, especially adapalene, leading underpinned by brand and generic competition.
- Price erosion is ongoing due to generic proliferation, with expected decreases of approximately 10% annually in the OTC segment.
- Revenue potential remains robust due to rising demand, but margins diminish as prices decline.
- OTC availability expands market reach; regulatory updates could influence pricing strategies.
- Competitors should prioritize differentiating through formulation improvements and marketing to sustain margins.
FAQs
1. What factors influence adapalene gel pricing?
Pricing is affected by patent status, generic availability, regulatory approvals (OTC or prescription), manufacturing costs, and competitive positioning.
2. How does OTC approval affect market dynamics?
OTC approval broadens the customer base and increases sales volume but intensifies price competition and reduces margins.
3. Are there upcoming regulatory changes that could impact pricing?
Future OTC switch approvals or new formulations could influence pricing, but no specific regulatory changes are imminent for adapalene.
4. What is the average profit margin for generic adapalene products?
Estimated profit margins range from 20% to 35%, varying with manufacturing scale and pricing strategies.
5. How does market penetration differ between branded and generic products?
Generic products dominate the market in volume (~75%), while branded products retain a higher per-unit price, maintaining overall revenue.
References
[1] Grand View Research. (2022). Acne Treatment Market Size, Share & Trends Analysis Report.
[2] IQVIA. (2023). Market Sales Data for Topical Acne Medications.
